Delays in diagnosis of acute pulmonary thromboembolism: Clinical outcomes and risk factors
Abstract
Keywords
Kaynakça
- Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investi- gation of thromboembolism etiology. Arch Intern Med 2002;162(10):1182-9.
- Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of low-dose aspirin on the occurrence of venous throm- boembolism: a randomized trial. Ann Intern Med 2007:16;147(8):525-33.
- Echegaray Agara M, Alonso Martínez JL, Urbieta Echezarreta MA, Abínzano Guillén ML, González Arencibia C, Solano Remírez M. [Pulmonary thromboembolism: long term course and clinical epidemiology]. An Med Interna 2003;20(9):451-6.
- Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and di- agnosis. Chest 2002;122(4):1440-56.
- Bulbul Y, Ozsu S, Kosucu P, Oztuna F, Ozlu T, Topbaş M. Time delay betweenonset of symptoms and diagnosis in pulmo- nary thromboembolism. Respiration 2009;78(1):36-41.
- Ageno W, Agnelli G, Imberti D, et al. and MASTER Investigators. Factors associated with the timing of di- agnosis of venous thromboembolism: results from the MASTER registry. Thromb Res 2008;121(6):751-6.
- Ozsu S, Oztuna F, Bulbul Y, et al. The role of risk factors in delayed diagnosis of pulmonary embolism. Am J Emerg Med 2011;29(1):26-32.
- Kucher N, Rossi E, De Rosa M, Goldhaber SZ. Massive pul- monary embolism. Circulation 2006;113(4):577-82.
Ayrıntılar
Birincil Dil
İngilizce
Konular
-
Bölüm
-
Yazarlar
Servet Kayhan
Bu kişi benim
Özgür İnce
Bu kişi benim
Meftun Ünsal
Bu kişi benim
Müfit Bakırcı
Bu kişi benim
Esra Arslan
Bu kişi benim
Yayımlanma Tarihi
1 Haziran 2012
Gönderilme Tarihi
27 Nisan 2015
Kabul Tarihi
-
Yayımlandığı Sayı
Yıl 2012 Cilt: 9 Sayı: 2